IC Class medications in patients with atrial fibrillation, arterial hypertension, chronic heart failure and intact systolic function

被引：0

作者：

Miller, O. N. ^{[1
]}

Skurikhina, O. N. ^{[1
]}

Starichkov, S. A. ^{[1
]}

机构：

[1] Novosibirsk State Med Univ, Novosibirsk, Russia

来源：

RUSSIAN JOURNAL OF CARDIOLOGY | 2008年 / 04期

关键词：

Atrial fibrillation; arterial hypertension; chronic heart failure; propanorm;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The study assessed clinical effectiveness and safety of propanorm in patients with arterial hypertension, chronic heart failure (CHF) without left ventricular systolic dysfunction, complicated with recurrent paroxysmal or persistent atrial AA fibrillation (AF). It was demonstrated that propanorm was effective and safe and could be combined with beta-adrenoblockers. In 29,3% of the participants, tachyarrhythmia terminated; in another 70,7% AF episode frequency reduced by 75,5%, and total time of AF episodes decreased by 81, 1%.

引用

页码：25 / 33

页数：9

共 50 条

[1] Effectiveness and safety of propafenone (Propanorm®) and amiodarone (Cordarone®) in patients with atrial fibrillation, arterial hypertension, coronary heart disease, and chronic heart failure with intact left ventricular systolic function
Miller, O. N.
Starichkov, S. A.
Pozdnyakov, Yu M.
Luchinsky, S. A.
Tarasov, A. V.
Doshchitsyn, V. L.
Kramynina, O. A.
Volkova, E. G.
Ilyinykh, D. L.
RUSSIAN JOURNAL OF CARDIOLOGY, 2010, (04): : 55 - 71
[2] Arterial hypertension as a heart failure predictor in patients with chronic glomerulonephritis and intact renal function
Borovkova, N. Yu.
Borovkov, N. N.
Koroleva, L. Yu.
Biryukova, L. A.
CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (05): : 6 - 10
[3] Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure
Zhao Qing-yan
Yu Sheng-bo
Huang He
Cui Hong-ying
Qin Mu
Huang Ting
Huang Cong-xin
CHINESE MEDICAL JOURNAL, 2012, 125 (10) : 1708 - 1712
[4] Predictors of systolic function recovery after atrial fibrillation ablation in heart failure patients
Borges-Rosa, Joao
Sousa, Pedro A.
Antonio, Natalia
Elvas, Luis
Goncalves, Lino
REVISTA PORTUGUESA DE CARDIOLOGIA, 2024, 43 (11) : 587 - 596
[5] DETERMINING THE RISK OF ATRIAL FIBRILLATION PAROXYSM IN PATIENTS WITH CHRONIC HEART FAILURE WITH INTACT AND REDUCED EJECTION FRACTION
Zakharov, I. P.
Chomakhidze, P. Sh
Kopylov, F. Yu
Sultygova, E. A.
Mesitskaya, D. F.
Lyubimova, E. A.
Andreev, D. A.
KARDIOLOGIYA, 2024, 64 (03) : 25 - 33
[6] Atorvastain effectiveness in patients with heart failure, preserved systolic function, and paroxysmal atrial fibrillation
Kozlova, E. S.
Popova, A. S.
Lopatin, Yu. M.
CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (06): : 35 - 43
[7] The impact of chronic heart failure on heart remodeling in patients with atrial fibrillation
Syvolap, V. V.
Lysenko, V. A.
ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (04) : 462 - 468
[8] CHRONIC RENAL DISEASE AND ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC HEART FAILURE
Shutov, A. M.
Serov, V. A.
Kurzina, E. V.
Gerdt, A. M.
Serova, D. V.
TERAPEVTICHESKII ARKHIV, 2009, 81 (12) : 23 - 26
[9] Right atrial structure and function in patients with hypertension and with chronic heart failure
Proplesch, Moritz
Merz, Allison A.
Claggett, Brian L.
Lewis, Eldrin F.
Dwyer, Kristin H.
Crousillat, Daniela R.
Lau, Emily S.
Silverman, Montane B.
Peck, Julie
Rivero, Jose
Cheng, Susan
Platz, Elke
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2018, 35 (07): : 905 - 914
[10] Endothelial adhesive function in patients with ischemic heart disease complicated by chronic heart failure and atrial fibrillation
Zakirova, A. N.
Abdukova, E. R.
Zakirova, N. E.
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (01) : 35 - 39

← 1 2 3 4 5 →